Latin Clinical Trial Center

What Latin Clinical Trial Center does

Latin Clinical Trial Center (LCTC) is a private clinical research site founded in August 2006 by Dr. Carlos A. Sariol in San Juan, Puerto Rico. The company executes Phase 1 through Phase 4 clinical trials — including protocols with pharmacokinetic sampling at multiple time points — for pharmaceutical sponsors, biotechnology companies, Contract Research Organizations (CROs), and NIH-funded research programs. Its service offering is built around an integrated private-practice physician network, with board-certified principal investigators and sub-investigators across gastroenterology, cardiology, rheumatology, neurology, pulmonology, gynecology, ophthalmology, internal medicine, family medicine, oncology, and pediatrics. The company positions a patient recruitment program drawing from a 100,000+-patient private practice pool and a 14,000-patient HMO relationship as a core differentiator, supported by an in-house operations team of Clinical Research Coordinators, a Regulatory Officer, Quality Control personnel, and administrative staff.

The underlying technology is a conventional, GCP-compliant clinical research facility rather than a software platform: a 2,100-square-foot dedicated site in San Juan with private exam rooms, secured medication storage, case report form and record storage, and a private monitor-visit office. All personnel are trained under GCP Guidelines, Human Subject Assurance, and IATA Training. There is no proprietary software product, AI/ML system, or integration platform described; the value is operational and human, not digital.

The business model is professional services revenue earned via direct contracting with sponsors and CROs. Go-to-market is direct enterprise field sales to pharmaceutical, biotech, and CRO buyers, supplemented by a referral channel through the PhaseWell Research multisite network and a Florida footprint via EFPMC in Tamarac. Pricing is contract-based per protocol and not publicly disclosed. The company is privately held, founder-controlled, and shows no disclosed institutional funding.

Name

Latin Clinical Trial Center

Legal name

Latin Clinical Trial Center

Website

https://latinclinicaltrialcenter.com

Company type

Private

Founded year

2006

Operating status

Operating

Short description

Latin Clinical Trial Center is a private clinical research site in San Juan, Puerto Rico, founded in 2006 by Dr. Carlos A. Sariol, that conducts Phase 1–4 trials for pharmaceutical, biotech, CRO, and NIH sponsors via an integrated private-practice physician network and a 100,000+-patient recruitment pool.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial services
• Phase I-IV studies
• Patient recruitment
• Clinical research site
• Pharmaceutical research services

Headquarters

HQ city

San Juan Capistrano

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Services: LCTC conducts Phase I-IV clinical research studies funded by Pharmaceutical Companies, Biotech Companies, Contract Research Organizations (CROs), and NIH-funded trials. Revenue is generated through service contracts for executing clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Latin Clinical Trial Center (LCTC) is a dedicated clinical research facility founded in 2006 that conducts Phase I-IV clinical research studies funded by pharmaceutical companies, biotech companies, Contract Research Organizations (CROs), and NIH-funded trials. The company integrates a private-practice physician network of board-certified specialists with comprehensive site management and a patient recruitment program drawing on 100,000+ potential participants to execute clinical trials across multiple therapeutic areas.

Product overview

Latin Clinical Trial Center (LCTC) is a dedicated clinical research facility that operates as a single unified offering focused on conducting Phase 1-4 clinical trials. Founded by Dr. Carlos A. Sariol in August 2006, LCTC provides clinical research services funded by pharmaceutical companies, biotech companies, Contract Research Organizations (CROs), and NIH-funded trials. The company integrates a private-practice physician network with comprehensive site management and patient recruitment services. LCTC has recently joined PhaseWell Research, expanding into a multisite clinical research network. The facility, located in San Juan, Puerto Rico, includes private exam rooms, secured medication storage, record storage, and monitor visit offices, staffed with board-certified principal investigators and experienced clinical research personnel trained under GCP Guidelines.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 18+ years conducting clinical studies in multiple indications
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• PhaseWell ResearchcoreStrategic or Co-development PartnerLatin Clinical Trial Center has joined PhaseWell Research, a multisite clinical research company dedicated to connecting communities to clinical trials and bringing hope today while shaping tomorrow's medicine. Learn more at www.phasewell.com. Contact email for privacy matters is [email protected].
• Pharmaceutical SponsorscoreStrategic or Co-development PartnerLCTC works with leaders in the Clinical Research Field, dedicated to assisting pharmaceutical development by providing focus on key areas such as Patient Enrollment, Data Collection, and Compliance. Multiple pharmaceutical company logos are displayed as sponsors.
• Contract Research Organizations (CROs)coreStrategic or Co-development PartnerLCTC partners with CROs providing site management and clinical trial execution services. The company focuses on key areas including patient enrollment, data collection, and compliance for CRO-managed trials.
• EFPMC (El Campo Physicians Medical Center)minorStrategic or Co-development PartnerEFPMC is a primary care outpatient practice established in 2015 by physicians, providing professional and compassionate high-quality care. EFPMC serves as LCTC's Florida network partner, with a medical team led by a board-certified internal medicine physician experienced in clinical research.
• HMO PartnersminorStrategic or Co-development PartnerLCTC has access to an HMO near their central office in San Juan, which covers an estimated population of 14,000 patients. This partnership supports patient recruitment for clinical trials.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Velocity Clinical Research: Largest U.S. dedicated clinical research site organization, conducting trials across multiple therapeutic areas for pharma and biotech sponsors. Directly comparable as an SMO with multi-site execution and similar customer base.
• Meridien Research: Independent clinical research site network conducting Phase II–IV trials across multiple therapeutic areas. Comparable to LCTC in business model, sponsor relationships, and site-based patient recruitment approach.
• Accel Research Sites: Network of multi-therapeutic clinical research sites serving pharmaceutical and biotech sponsors. Highly comparable to LCTC as an independent, multi-specialty site network executing Phase I–IV trials with similar patient recruitment models.
• Benchmark Research: Multi-site clinical research organization serving pharmaceutical sponsors across a range of indications. Comparable to LCTC as an independent SMO competing for Phase I–IV trial allocations.
• Research Centers of America: Clinical research site organization executing trials across multiple therapeutic areas for pharma and biotech sponsors. Comparable to LCTC as an independent site competing for similar study protocols.

Broad incumbents

• ICON plc: Major global CRO with site management and clinical trial delivery capabilities serving the same pharma/biotech customer base. Comparable as a clinical research services provider at the customer and category level.
• Medpace: Mid-to-large CRO focused on Phase II–IV clinical trial execution for pharma and biotech sponsors. Comparable to LCTC as a clinical trial services provider, though operating at much greater scale and as a CRO rather than a site.
• Syneos Health: Global CRO with dedicated clinical trial site operations serving pharmaceutical and biotech sponsors. Comparable as a clinical trial delivery provider, though substantially larger and broader than LCTC.
• IQVIA: Largest global CRO with an embedded clinical trial site network serving the same pharma/biotech sponsor base as LCTC. Comparable at the customer and category level, though IQVIA is a much broader incumbent spanning CRO, technology, and data services.
• PPD (Thermo Fisher Scientific): Global CRO with site operations and clinical trial execution services. Comparable to LCTC as a sponsor-facing clinical trial delivery organization, though much larger in scale and scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Latin Clinical Trial Center